
Enzon Pharmaceuticals, Inc. has closed the sale of its specialty pharmaceutical business to sigma-tau. The specialty pharmaceutical business sold includes four marketed products, Abelcet® (amphotericin B lipid complex injection), Adagen® (pegademase bovine), Depocyt® (cytarabine liposome injection), and Oncaspar® (pegaspargase), as well as the manufacturing facility in Indianapolis, Indiana. In the future, please refer to www.sigmatau.com for information regarding these products and services.
Enzon is continuing to assist sigma-tau in supporting these products for a limited time. Enzon’s Medical Information hotline (866-792-5172) and Drug Safety hotline (800-836-4301) are available to receive questions or adverse event reports.
| (ENZN) NASDAQ | |||
| Last Trade | 9.00 | ||
| Change(%) | ![]() | 0.00 | |
| Volume | 0 | ||
| 4:12 AM - Feb 09, 2010 | |||